ATS 2018 - ILD Congress Highlights
The American Thoracic Society (ATS) brought together specialists working in respiratory medicine at its annual international congress in San Diego, USA (May 18th-23rd 2018).
With over 500 sessions and more than 800 speakers, the conference was a great success covering up-to-date developments in pulmonary research, critical care, and sleep medicine.
In numerous interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) sessions, clinicians, researchers, and related health care professionals from all around the globe came together to present and discuss the latest scientific research and findings in the field.
The ATS Congress Highlights report was developed in close cooperation with two renowned experts in the field of interstitial lung diseases, Dr. Francesco Bonella (Ruhrland Klinik, Essen, Germany) and Dr. Ivan Rosas (Brigham and Women's Hospital, Boston, USA), who share their personal picks of the most clinically relevant topics discussed at the congress.
Read this report to gain an in-depth understanding of the key topics in IPF/ILD that were presented, including:
- Latest breakthroughs
- New insights into ILD diagnosis and management
- IPF pathobiology
- Non-IPF ILDs